Amplification of Wild-Type RET Represents a Novel Molecular Subtype of Several Cancer Types With Clinical Response to Selpercatinib.
Malini M GandhiBiagio RicciutiGuilherme HaradaMatteo RepettoMelissa S GildenbergAnkit SinghYvonne Y LiAndréanne GagnéXinan WangAyal A AizerKelly N FitzgeraldMizuki NishinoJoao M Victor AlessiFederica PecciAlessandro Di FedericoAdam S FischAlexander E DrilonValentina NardiLynette M ShollMark M AwadJulia RotowPublished in: JCO precision oncology (2023)
represents a novel, targetable molecular subset of cancer.